SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-130462
Filing Date
2023-05-01
Accepted
2023-05-01 16:16:07
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d496980d10ka.htm   iXBRL 10-K/A 277531
2 EX-31.1 d496980dex311.htm EX-31.1 3877
3 EX-31.2 d496980dex312.htm EX-31.2 3871
  Complete submission text file 0001193125-23-130462.txt   513271

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA freq-20221231.xsd EX-101.SCH 5012
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE freq-20221231_cal.xml EX-101.CAL 699
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE freq-20221231_def.xml EX-101.DEF 1704
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20221231_lab.xml EX-101.LAB 21946
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20221231_pre.xml EX-101.PRE 17133
10 EXTRACTED XBRL INSTANCE DOCUMENT d496980d10ka_htm.xml XML 8047
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39062 | Film No.: 23873882
SIC: 2834 Pharmaceutical Preparations